Sonder Capital | Futures II

vcCo-invests

◆ Check Size

$0.5M→$10.0M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Focus on AI-enabled medical robotics and minimally invasive therapies, fueling companies creating entirely new care pathways and business models to create new standards of care in distributed settings.

◆ About Sonder Capital

Early-stage venture capital firm investing in medical device, diagnostic, and healthtech companies; describes itself as a foundational investor that supports companies from inception to acquisition or IPO.

◆ Sectors

MedtechRoboticsGenerative AIDiagnosticsDigital Health

◆ Stages

seedseries-aseries-b

◆ Geography Focus

global

◆ Team

Name	Title	Role	Links
Andy McGibbon	Partner	—	in
Colby Wood	Co-Founder and Partner, Capital Formation	—	in
Deborah Kilpatrick, Ph.D.	Venture Partner	—	in
Fred Moll	co-founder & partner	—	in
Fred Moll, M.D.	Co-Chair and Partner	—	in
Jay Watkins	Co-Chair and Partner	—	in
Kate Garrett	managing partner	—	in

◆ Notable Investments

VitestroWondr MedicalGI WindowsAvailIntuitive SurgicalShockwave MedicalProcept BioroboticsAuris HealthReflexion MedicalSquareMindManual Phlebotomy

◆ Traits

Co-invests

◆ FAQ

What does Futures II invest in?

Futures II invests in Medtech, Robotics, Generative AI, Diagnostics and Digital Health at the seed, series-a and series-b stages.

Which geographies does Futures II focus on?

Futures II focuses on global, and is headquartered in United States.

What is Futures II's typical check size?

Futures II typically writes checks of $0.5M to $10M.